Believe the Hype: A Cure for Alzheimer's Is in Reach The recent breakthroughs in Alzheimer's disease research have created a wave of excitement among patients, families, and even the general public.
Two new treatments, lecanemab and donanemab, have made their way onto pharmacy shelves, promising to slow the progression of this debilitating disease. But is this newfound optimism justified?
Or are we once again getting ahead of ourselves? The past few years have seen a flurry of attention grabbing headlines touting "cures" for Alzheimer's, only to be followed by a disappointing reality.